TG Therapeutics, Inc. (TGTX)
39.36
-0.37
(-0.93%)
USD |
NASDAQ |
May 27, 15:52
TG Therapeutics Free Cash Flow : -14.19M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Krystal Biotech, Inc. | 237.38M |
| Precision BioSciences, Inc. | -54.23M |
| AnaptysBio, Inc. | 4.409M |
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| Geron Corp. | -126.13M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.89M |
| Cash from Investing (Quarterly) | -9.864M |
| Cash from Financing (Quarterly) | 390.83M |
| Free Cash Flow Per Share (Quarterly) | -0.1121 |
| Free Cash Flow to Equity (Quarterly) | -517.79M |
| Free Cash Flow to Firm (Quarterly) | -10.50M |
| Free Cash Flow Yield | -0.22% |